GA
BIIB icon

Geneva Advisors’s Biogen BIIB Stock Holding History

Geneva Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,365
Closed -$2.87M – 721
2015
Q4 		$2.87M Sell
9,365
-18,997
-67% -$5.46M 0.06% 149
2015
Q3 		$8.28M Sell
28,362
-150,959
-84% -$49.9M 0.17% 97
2015
Q2 		$72.4M Buy
179,321
+1,678
+0.9% +$673K 1.29% 25
2015
Q1 		$75M Buy
177,643
+9,940
+6% +$3.92M 1.36% 23
2014
Q4 		$56.9M Buy
167,703
+38,230
+30% +$12.4M 1.06% 37
2014
Q3 		$42.8M Buy
129,473
+123,342
+2,012% +$40.7M 0.81% 51
2014
Q2 		$1.93M Sell
6,131
-2,129
-26% -$641K 0.04% 205
2014
Q1 		$2.53M Buy
8,260
+40
+0.5% +$12.7K 0.05% 186
2013
Q4 		$2.3M Sell
8,220
-19,045
-70% -$4.93M 0.04% 156
2013
Q3 		$6.56M Buy
27,265
+14,440
+113% +$3.23M 0.14% 106
2013
Q2 		$2.76M Buy
+12,825
New +$2.74M 0.06% 129

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geneva Advisors's BIIB Position: Q1 2016 in Review

Geneva Advisors sold out of Biogen (BIIB) in Q1 2016, closing a stake of 9,365 shares — an estimated $2.87M sold.

Geneva Advisors first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $75M in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Geneva Advisors reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Geneva Advisors sold 9,365 Biogen shares in Q1 2016, an estimated $2.87M.
  • Geneva Advisors first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
  • Geneva Advisors's Biogen position peaked at $75M in Q1 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.